N'-[3-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)propyl]-4-(1,3-thiazol-2-yl)piperazine-1-carboximidamide;hydroiodide

C16H26IN7OS — CID 111080324

IUPACN'-[3-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)propyl]-4-(1,3-thiazol-2-yl)piperazine-1-carboximidamide;hydroiodide
SMILESCC(C)c1noc(CCC/N=C(\N)N2CCN(c3nccs3)CC2)n1.I
InChIInChI=1S/C16H25N7OS.HI/c1-12(2)14-20-13(24-21-14)4-3-5-18-15(17)22-7-9-23(10-8-22)16-19-6-11-25-16;/h6,11-12H,3-5,7-10H2,1-2H3,(H2,17,18);1H
InChIKeyIMVGEFFPHNJGKW-UHFFFAOYSA-N
MW491.40 g/mol
LogP2.34
Rot. Bonds6

About N'-[3-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)propyl]-4-(1,3-thiazol-2-yl)piperazine-1-carboximidamide;hydroiodide

N'-[3-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)propyl]-4-(1,3-thiazol-2-yl)piperazine-1-carboximidamide;hydroiodide (PubChem CID 111080324) has the molecular formula C16H26IN7OS and a molecular weight of 491.40 g/mol. Its IUPAC name is N'-[3-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)propyl]-4-(1,3-thiazol-2-yl)piperazine-1-carboximidamide;hydroiodide.

Molecular Properties

Compound NameN'-[3-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)propyl]-4-(1,3-thiazol-2-yl)piperazine-1-carboximidamide;hydroiodide
PubChem CID111080324
Molecular FormulaC16H26IN7OS
Molecular Weight491.40 g/mol
Exact Mass491.10
IUPAC NameN'-[3-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)propyl]-4-(1,3-thiazol-2-yl)piperazine-1-carboximidamide;hydroiodide
SMILESCC(C)c1noc(CCC/N=C(\N)N2CCN(c3nccs3)CC2)n1.I
InChIInChI=1S/C16H25N7OS.HI/c1-12(2)14-20-13(24-21-14)4-3-5-18-15(17)22-7-9-23(10-8-22)16-19-6-11-25-16;/h6,11-12H,3-5,7-10H2,1-2H3,(H2,17,18);1H
InChIKeyIMVGEFFPHNJGKW-UHFFFAOYSA-N
XLogP2.34
TPSA96.67 Ų
H-Bond Donors1
H-Bond Acceptors7
Rotatable Bonds6
Heavy Atoms26
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500491.40
LogP ≤ 52.34
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}, {'alert_name': 'iodine', 'substructure': 'N/A'}

Analyze N'-[3-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)propyl]-4-(1,3-thiazol-2-yl)piperazine-1-carboximidamide;hydroiodide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N'-[3-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)propyl]-4-(1,3-thiazol-2-yl)piperazine-1-carboximidamide;hydroiodide?
The IUPAC name of N'-[3-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)propyl]-4-(1,3-thiazol-2-yl)piperazine-1-carboximidamide;hydroiodide (CID 111080324) is N'-[3-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)propyl]-4-(1,3-thiazol-2-yl)piperazine-1-carboximidamide;hydroiodide.
What is the SMILES notation for N'-[3-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)propyl]-4-(1,3-thiazol-2-yl)piperazine-1-carboximidamide;hydroiodide?
The canonical SMILES for N'-[3-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)propyl]-4-(1,3-thiazol-2-yl)piperazine-1-carboximidamide;hydroiodide is CC(C)c1noc(CCC/N=C(\N)N2CCN(c3nccs3)CC2)n1.I.
What is the InChIKey of N'-[3-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)propyl]-4-(1,3-thiazol-2-yl)piperazine-1-carboximidamide;hydroiodide?
The InChIKey is IMVGEFFPHNJGKW-UHFFFAOYSA-N. The full InChI is InChI=1S/C16H25N7OS.HI/c1-12(2)14-20-13(24-21-14)4-3-5-18-15(17)22-7-9-23(10-8-22)16-19-6-11-25-16;/h6,11-12H,3-5,7-10H2,1-2H3,(H2,17,18);1H.
What are the key properties of N'-[3-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)propyl]-4-(1,3-thiazol-2-yl)piperazine-1-carboximidamide;hydroiodide?
N'-[3-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)propyl]-4-(1,3-thiazol-2-yl)piperazine-1-carboximidamide;hydroiodide has a molecular weight of 491.40 g/mol, XLogP of 2.34, 6 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N'-[3-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)propyl]-4-(1,3-thiazol-2-yl)piperazine-1-carboximidamide;hydroiodide is sourced from PubChem (CID 111080324), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).